Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.

about

S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.

P2860

Q33648661-CEC0C820-42CF-47A4-9FEE-B30A1C16D1C8

P2860

Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.

Item

http://www.wikidata.org/entity/Q51643436

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Napsin A/p40 antibody cocktail ...... gy and small biopsy specimens.

@en

Napsin A/p40 antibody cocktail ...... gy and small biopsy specimens.

@nl

type

Item

label

Napsin A/p40 antibody cocktail ...... gy and small biopsy specimens.

@en

Napsin A/p40 antibody cocktail ...... gy and small biopsy specimens.

@nl

prefLabel

Napsin A/p40 antibody cocktail ...... gy and small biopsy specimens.

@en

Napsin A/p40 antibody cocktail ...... gy and small biopsy specimens.

@nl

P1476

Napsin A/p40 antibody cocktail ...... gy and small biopsy specimens.

@en

P2093

Eugene J Mark

http://www.w3.org/2001/XMLSchema#string

Mai P Hoang

http://www.w3.org/2001/XMLSchema#string

Mari Mino-Kenudson

http://www.w3.org/2001/XMLSchema#string

Michiya Nishino

http://www.w3.org/2001/XMLSchema#string

Patricia Della Pelle

http://www.w3.org/2001/XMLSchema#string

Tiffany G Huynh

http://www.w3.org/2001/XMLSchema#string

Vicente Morales-Oyarvide

http://www.w3.org/2001/XMLSchema#string

P2860

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.

RET, ROS1 and ALK fusions in lung cancer.

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification

P304

472-484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCY.21707

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27412420

http://www.w3.org/2001/XMLSchema#string

Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.

about

P2860

P2860

Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698